# Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

> **NCT04478084** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 403 (actual)

## Conditions studied

- Rabies (Healthy Volunteers)

## Interventions

- **BIOLOGICAL:** Purified vero rabies vaccine - serum free VRVg-2
- **BIOLOGICAL:** Purified inactivated rabies vaccine
- **BIOLOGICAL:** Equine rabies immunoglobulins (ERIG) (only Group 3 and Group 4)
- **BIOLOGICAL:** Human rabies immunoglobulins (HRIG) (only Group 5 and Group 6)

## Key facts

- **NCT ID:** NCT04478084
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-04
- **Primary completion:** 2022-03-19
- **Final completion:** 2022-07-21
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04478084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04478084, "Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04478084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*